Thermo Scientific™

TheraPure™ GMP RNase Inhibitor, 40 U/μL

Número de catálogo: EO038SKB011
Thermo Scientific™

TheraPure™ GMP RNase Inhibitor, 40 U/μL

Número de catálogo: EO038SKB011
Número de catálogo
EO038SKB011
Tamaño de la unidad
40 kU
Precio (CLP)
Número de catálogo
Tamaño de la unidad
400 kU
Precio (CLP)
Número de catálogo
Tamaño de la unidad
2000 kU
Precio (CLP)
Número de catálogo
Tamaño de la unidad
8000 kU
Precio (CLP)
Número de catálogoTamaño de la unidadPrecio (CLP)
EO038SKB01140 kUContáctenos ›
EO038AFSKB001400 kUContáctenos ›
EO038AFB0362000 kUContáctenos ›
EO038SKB0078000 kUContáctenos ›
Descripción general del producto
Figuras
Videos
Recomendaciones
Recomendaciones
Documentos
Preguntas frecuentes
Citas y referencias
Información adicional
Recomendaciones

Thermo Scientific TheraPure GMP* RNase Inhibitor is manufactured to ICH Q7 GMP principles and supported by a comprehensive documentation package. It is designed to prevent RNA degradation during development and manufacturing of mRNA therapeutics. As a potent noncompetitive inhibitor of RNases A, B, and C, it allows the newly synthesized RNA of in vitro transcription to remain intact.

Designed for process development and manufacturing
TheraPure GMP RNase inhibitor helps accelerate mRNA vaccine and therapeutics production from preclinical development to commercialization by providing:
Quality—meet critical product quality needs to help accelerate therapeutic development and manufacturing
Minimal risk—helps reduce risks in developing therapeutics by utilizing proven products
Technical partnership—partner with expert product and technical support
Secure and consistent supply—count on a secure and stable supply of product at a global scale

Comprehensive quality system
TheraPure GMP RNase inhibitor is supported by a extensive quality system and documentation including:
• Manufactured to relevant ICH Q7 GMP guidelines
• Animal-origin free (AOF) manufacturing processes, materials, and facilities
• Validated manufacturing processes and analytical test methods
• Comprehensive impurity profiles
• Verified compendial assays where applicable
• Product stability data
• Tested by analytical methods following ICH Q2 guidelines whenever possible
• Drug master file (DMF)

Enzyme activity
One unit is the amount of protein required to reduce the activity of 5 ng of RNase A by 50%.

For additional TheraPure GMP products or customization, please visit www.thermofisher.com/therapure.

*TheraPure GMP refers to the quality level of the raw, ancillary, or starting materials to be used for further manufacturing. TheraPure GMP products are manufactured in facilities with ISO 9001–certified quality management systems that operate in accordance with relevant good manufacturing practice (GMP) principles, as outlined in ICH Q7 or equivalent guidance documents or standards.

For Research Use or Further Manufacturing. Not for diagnostic use or direct administration into humans or animals.

Especificaciones

Concentración
40 U/μL
Color
Transparent
Pureza
≥95%
pH
7.6 to 8.4
Para utilizar con (aplicación)
In vitro transcription
Tampón de almacenamiento
20 mM Tris-HCl, pH 8, 50 mM KCl, 0.5 mM EDTA, 8 mM DTT, 50% (v/v) glycerol
Sistema de expresión
E. coli
Masa
52 kDa
Enzima
RNase Inhibitor
Fuente
Porcine gene
Cantidad
40 kU
Tipo de producto
RNase Inhibitor
Línea de productos
TheraPure™ GMP
Actividad biológica
RNase Inhibitor
Formulario
Liquid

Figuras

Documentos y descargas

Certificados

    Preguntas frecuentes

    Citas y referencias

    Search citations by name, author, journal title or abstract text